rs6151415

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 3P and 20B. PM1PP2BP4_StrongBP6_Very_StrongBA1

The NM_000487.6(ARSA):​c.585G>T​(p.Trp195Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0685 in 1,613,172 control chromosomes in the GnomAD database, including 4,413 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.051 ( 275 hom., cov: 33)
Exomes 𝑓: 0.070 ( 4138 hom. )

Consequence

ARSA
NM_000487.6 missense

Scores

7
10

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 1.05

Publications

27 publications found
Variant links:
Genes affected
ARSA (HGNC:713): (arylsulfatase A) The protein encoded by this gene hydrolyzes cerebroside sulfate to cerebroside and sulfate. Defects in this gene lead to metachromatic leucodystrophy (MLD), a progressive demyelination disease which results in a variety of neurological symptoms and ultimately death. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Dec 2010]
ARSA Gene-Disease associations (from GenCC):
  • metachromatic leukodystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, ClinGen
  • metachromatic leukodystrophy, juvenile form
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

PM1
In a hotspot region, there are 8 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 2 benign, 14 uncertain in NM_000487.6
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 159 curated pathogenic missense variants (we use a threshold of 10). The gene has 11 curated benign missense variants. Gene score misZ: 0.38013 (below the threshold of 3.09). Trascript score misZ: -0.56919 (below the threshold of 3.09). GenCC associations: The gene is linked to metachromatic leukodystrophy, juvenile form, metachromatic leukodystrophy.
BP4
Computational evidence support a benign effect (MetaRNN=0.004769802).
BP6
Variant 22-50626933-C-A is Benign according to our data. Variant chr22-50626933-C-A is described in ClinVar as Benign. ClinVar VariationId is 93125.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0754 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARSANM_000487.6 linkc.585G>T p.Trp195Cys missense_variant Exon 3 of 8 ENST00000216124.10 NP_000478.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARSAENST00000216124.10 linkc.585G>T p.Trp195Cys missense_variant Exon 3 of 8 1 NM_000487.6 ENSP00000216124.5

Frequencies

GnomAD3 genomes
AF:
0.0511
AC:
7779
AN:
152216
Hom.:
276
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0150
Gnomad AMI
AF:
0.0833
Gnomad AMR
AF:
0.0340
Gnomad ASJ
AF:
0.0810
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.0151
Gnomad FIN
AF:
0.0780
Gnomad MID
AF:
0.0665
Gnomad NFE
AF:
0.0772
Gnomad OTH
AF:
0.0507
GnomAD2 exomes
AF:
0.0529
AC:
13189
AN:
249174
AF XY:
0.0535
show subpopulations
Gnomad AFR exome
AF:
0.0127
Gnomad AMR exome
AF:
0.0277
Gnomad ASJ exome
AF:
0.0750
Gnomad EAS exome
AF:
0.000164
Gnomad FIN exome
AF:
0.0752
Gnomad NFE exome
AF:
0.0768
Gnomad OTH exome
AF:
0.0586
GnomAD4 exome
AF:
0.0703
AC:
102707
AN:
1460838
Hom.:
4138
Cov.:
34
AF XY:
0.0691
AC XY:
50188
AN XY:
726720
show subpopulations
African (AFR)
AF:
0.0110
AC:
367
AN:
33480
American (AMR)
AF:
0.0281
AC:
1258
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0691
AC:
1805
AN:
26132
East Asian (EAS)
AF:
0.000151
AC:
6
AN:
39700
South Asian (SAS)
AF:
0.0224
AC:
1933
AN:
86256
European-Finnish (FIN)
AF:
0.0718
AC:
3766
AN:
52476
Middle Eastern (MID)
AF:
0.0517
AC:
298
AN:
5768
European-Non Finnish (NFE)
AF:
0.0806
AC:
89645
AN:
1111936
Other (OTH)
AF:
0.0601
AC:
3629
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
6869
13739
20608
27478
34347
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3266
6532
9798
13064
16330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0511
AC:
7778
AN:
152334
Hom.:
275
Cov.:
33
AF XY:
0.0502
AC XY:
3738
AN XY:
74496
show subpopulations
African (AFR)
AF:
0.0150
AC:
623
AN:
41594
American (AMR)
AF:
0.0339
AC:
519
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0810
AC:
281
AN:
3470
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5184
South Asian (SAS)
AF:
0.0153
AC:
74
AN:
4826
European-Finnish (FIN)
AF:
0.0780
AC:
828
AN:
10620
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.0772
AC:
5249
AN:
68018
Other (OTH)
AF:
0.0502
AC:
106
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
394
788
1183
1577
1971
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0676
Hom.:
1033
Bravo
AF:
0.0458
TwinsUK
AF:
0.0747
AC:
277
ALSPAC
AF:
0.0825
AC:
318
ESP6500AA
AF:
0.0170
AC:
75
ESP6500EA
AF:
0.0771
AC:
663
ExAC
AF:
0.0527
AC:
6402
Asia WGS
AF:
0.00808
AC:
28
AN:
3478
EpiCase
AF:
0.0796
EpiControl
AF:
0.0787

ClinVar

Significance: Benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 23, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Metachromatic leukodystrophy Benign:4
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jun 29, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 15, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Jul 25, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 31836585, 28670130, 8897113) -

Citrullinemia Benign:1
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.52
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Uncertain
-0.080
CADD
Pathogenic
26
DANN
Uncertain
0.99
DEOGEN2
Benign
0.23
T;T;T;.;T
Eigen
Benign
0.0048
Eigen_PC
Benign
0.041
FATHMM_MKL
Benign
0.70
D
LIST_S2
Uncertain
0.86
.;.;.;D;D
MetaRNN
Benign
0.0048
T;T;T;T;T
MetaSVM
Benign
-0.32
T
PhyloP100
1.0
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-0.73
N;N;N;N;N
REVEL
Uncertain
0.42
Sift
Benign
0.036
D;D;D;D;D
Sift4G
Uncertain
0.032
D;D;D;T;D
Vest4
0.49
ClinPred
0.010
T
GERP RS
3.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
gMVP
0.90
Mutation Taster
=71/29
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6151415; hg19: chr22-51065361; COSMIC: COSV53350176; COSMIC: COSV53350176; API